Is Prophylactic Irradiation After Chest Wall Procedure Beneficial in Mesothelioma?
May 30, 2019
Researchers tested whether prophylactic irradiation after a chest wall procedure would benefit patients with malignant pleural mesothelioma.
Christina Bennett, MS
Can Crowdsourcing Lead to Artificial Intelligence Tools for Radiation Oncologists?
May 22, 2019
A worldwide crowd innovation contest incentivized international programmers to create automated AI algorithms for an area of radiation oncology.
First-Line Therapy for Metastatic RCC Remains Controversial Amid New Approvals
May 16, 2019
The bar for the standard of care among patients with advanced renal cell carcinoma is set high as various promising combination therapies recently received FDA approval.
Long-Term Data Support Stereotactic Body Radiotherapy for Centrally Located NSCLC
May 9, 2019
The findings further validate the initial 2015 findings that a five-fraction SBRT schedule is appropriate for patients with centrally located NSCLC.
Does Hypothyroidism Impact Risk of Breast Cancer Recurrence or Death?
May 8, 2019
Researchers evaluated whether breast cancer patients with hypothyroidism at diagnosis or who develop it later have an increased risk of recurrence or death.
Exercise Proves Beneficial for Breast Cancer Survivors, Yet Again
May 8, 2019
The results of a new study add to the list of benefits seen with exercise among breast cancer survivors: reducing the risk of cardiovascular disease.
Pembrolizumab Provides Hope for PD-L1–Positive Cervical Cancer Patients
May 7, 2019
The phase II KEYNOTE-158 basket trial evaluated single-agent pembrolizumab in patients with previously treated advanced cervical cancer.
Incidence of Adverse Events for PD-1/PD-L1 Inhibitors Underscores Toxicity Risk
May 7, 2019
A review and meta-analysis in JAMA Oncology evaluated the incidence of treatment-related adverse events in patients receiving PD-1 or PD-L1 therapy.
Early Results for Next-Generation TRK Inhibitor LOXO-195 Look “Very Promising”
April 23, 2019
The investigators tested the agent in patients who had solid tumors with NTRK gene fusions that had developed resistance to other TRK inhibitors.
Is It Too Soon to Augment Lung Cancer Screening Guidelines for High-Risk Patients?
April 12, 2019
A study looked at whether a lung cancer risk prediction model could identify patients at high risk for lung cancer who could receive less frequent low-dose CT screening.
